Background: Characteristics of intensive care unit (ICU) downgrades who experience a complicated post-ICU ward course (ICU return or floor death) and the incidence of this phenomenon have not been examined in ICU survivors of coronavirus disease 2019 (COVID-19) pneumonia. The aim of the present study was to establish the rate of a complicated post-ICU ward course among survivors of COVID-19 pneumonia and describe the associated patient, ICU management, and serum biomarker characteristics. An additional aim was to compare these parameters between those who experienced a complicated post-ICU course and those who did not.
Methods: This was a retrospective study of patients who were admitted to the ICU with COVID-19 pneumonia and were downgraded to a hospital floor at the end of their initial ICU stay. Patients were divided based on a complicated or uncomplicated post-ICU course. Groups were compared with respect to relevant clinical variables. Serum biomarker levels were compared on day of ICU exit and were trended in the days preceding the downgrade. Ward stay of patients who had a complicated course was examined for notable floor events surrounding their decompensation.
Results: Eighteen out of 99 downgraded patients (18%) experienced a complicated post-ICU course, among them there were 14 returns (14%) and four deaths (4%). They had higher Charlson Comorbidity Index, higher Acute Physiology and Chronic Health Evaluation (APACHE) IV score, as well as higher D-dimer and C-reactive protein (CRP) at ICU departure. They were less likely to have received therapeutic anticoagulation and convalescent plasma during their ICU stay. On multivariable analysis, these parameters except D-dimer remained independently associated with a complicated course. Review of biomarker trends preceding ICU exit demonstrated an upward trajectory of D-dimer, CRP, and lactate dehydrogenase (LDH) in the complicated course group not mirrored by the uncomplicated course group. Examination of notable floor events leading up to decompensation revealed that in 50% the ward course was characterized by new cardiac disturbances.
Conclusions: Our rate of ward death among ICU downgrades was similar to pre-COVID data, but the rate of ICU return was higher. Complicated post-ICU course patients were exhibiting upward biomarker trends at ICU exit, and their ward stay was punctuated by acute cardiac abnormalities.
Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC8670769 | PMC |
| http://dx.doi.org/10.14740/jocmr4555 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Nomogram model for predicting secondary infection in critically ill patients with heatstroke: A pilot study from China.
PLoS One
December 2024
The First Clinical Medical College, Southern Medical University, Guangzhou, Guangdong, China.
Objective: In this retrospective analysis, we explored the clinical characteristics and risk factors of secondary infections in patients with severe heatstroke with the aim to gain epidemiological insights and identify risk factors for secondary infections.
Method: The study included 129 patients with severe heatstroke admitted to the General Hospital of the Southern Theater Command of the PLA between January 1, 2011, and December 31, 2021. Patients were divided into an infection group (n = 24) and a non-infection group (n = 105) based on infection occurrence within 48 h of intensive care unit (ICU) admission.
Long-Term Cognitive Function Among Critical Illness Survivors.
Crit Care Clin
January 2025
Department of Critical Care Medicine, Queen's University, 76 Stuart Street, Kingston, Ontario K7A 2V7, Canada; Division of Neurology, Department of Medicine, Queen's University, 76 Stuart Street, Kingston, Ontario K7A 2V7, Canada. Electronic address: https://twitter.com/jgordonboyd.
Cognitive impairment is common after critical illness and persists beyond the period of acute illness. Clinicians caring for this patient population are encouraged to screen for cognitive impairment and provide supportive measures to mitigate its distressing effects. Further research is needed to evaluate the laboratory and neuroimaging correlates of post-intensive care unit (ICU) cognitive impairment, which may in turn lead to personalized interventions to address this debilitating complication of critical illness.
View Article and Find Full Text PDFCognitive recovery of post critical care patients with and without COVID-19: differences and similarities, an observational study.
Neurol Res Pract
October 2024
Clinic for Neurological Rehabilitation, Fachklinik Für Neurologische Frührehabilitation, Kliniken Beelitz GmbH, Paracelsusring 6a, Beelitz-Heilstätten, 14547, Brandenburg, Germany.
Background: Coronavirus disease (COVID-19) patients treated in an intensive care unit (ICU) are at high risk of developing cognitive impairments of a "post-intensive care syndrome" (PICS). We explored whether critically ill COVID-19 and non-COVID-19 survivors differ in their post-ICU recovery course in terms of severity and affected cognitive domains.
Methods: An observational prospective study was conducted in a German post-acute neurological early rehabilitation clinic.
Short- and long-term outcomes in critically ill patients with primary glomerular disease: a case‒control study.
BMC Nephrol
October 2024
Medical Sciences Postgraduate Program, Universidade de Fortaleza- UNIFOR, Fortaleza, Ceará, Brazil.
Article Synopsis
- Study explores the impact of primary glomerulopathy on critically ill patients in the ICU, finding that infections and cardiovascular issues are common admission causes and sepsis is prevalent among these patients.
- Among 307 patients analyzed, hospital mortality rates were similar to controls, but long-term mortality was high at 29% three years after ICU discharge, with reduced urine output and serum albumin levels being key predictors.
- Findings indicate unique characteristics of this patient group, stressing the need for thorough risk assessment, while an unexpected lack of association between acute kidney injury and mortality warrants further investigation.
TGF-β1 overexpression in severe COVID-19 survivors and its implications for early-phase fibrotic abnormalities and long-term functional impairment.
Front Immunol
September 2024
Respiratory Diseases Group, Respiratory Service, La Paz University Hospital, IdiPAZ, Madrid, Spain.
Introduction: In post-COVID survivors, transforming growth factor-beta-1 (TGF-β1) might mediate fibroblast activation, resulting in persistent fibrosis.
Methods: In this study, 82 survivors of COVID-19-associated ARDS were examined at 6- and 24-months post-ICU discharge. At 6-months, quantitative CT analysis of lung attenuation was performed and active TGF-β1 was measured in blood and exhaled breath condensate (EBC).
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!